FCIM
LH icon

Fairview Capital Investment Management’s Labcorp LH Stock Holding History

Fairview Capital Investment Management’s Portfolio LH Stock Details LH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$61.5M Sell
230,405
-1,615
-0.7% -$437K 3.34% 9
2025
Q4 		$58.2M Sell
232,020
-934
-0.4% -$248K 2.99% 11
2025
Q3 		$66.9M Sell
232,954
-1,923
-0.8% -$515K 3.39% 10
2025
Q2 		$61.7M Buy
234,877
+9,199
+4% +$2.24M 3.19% 11
2025
Q1 		$52.5M Sell
225,678
-162
-0.1% -$39.3K 2.78% 12
2024
Q4 		$51.8M Buy
225,840
+3,978
+2% +$913K 2.69% 13
2024
Q3 		$49.6M Sell
221,862
-3,722
-2% -$818K 2.68% 12
2024
Q2 		$45.9M Sell
225,584
-3,548
-2% -$722K 2.58% 12
2024
Q1 		$50.1M Buy
229,132
+6,409
+3% +$1.41M 2.82% 10
2023
Q4 		$50.6M Buy
222,723
+2,136
+1% +$449K 3.01% 12
2023
Q3 		$44.3M Sell
220,587
-36,834
-14% -$7.77M 2.84% 12
2023
Q2 		$53.4M Sell
257,421
-1,961
-0.8% -$380K 3.37% 10
2023
Q1 		$51.1M Sell
259,382
-391
-0.2% -$80.5K 3.34% 10
2022
Q4 		$52.6M Buy
259,773
+1,398
+0.5% +$273K 3.6% 10
2022
Q3 		$45.5M Buy
258,375
+3,184
+1% +$652K 3.25% 10
2022
Q2 		$51.4M Buy
255,191
+3,422
+1% +$729K 3.56% 9
2022
Q1 		$57M Sell
251,769
-662
-0.3% -$156K 3.55% 9
2021
Q4 		$68.1M Buy
252,431
+2,230
+0.9% +$552K 4.36% 6
2021
Q3 		$60.5M Sell
250,201
-948
-0.4% -$239K 4.13% 6
2021
Q2 		$59.5M Sell
251,149
-1,320
-0.5% -$301K 4.09% 6
2021
Q1 		$55.3M Sell
252,469
-62
-0% -$12.4K 1.99% 12
2020
Q4 		$44.2M Buy
252,531
+1,639
+0.7% +$283K 1.81% 20
2020
Q3 		$40.6M Sell
250,892
-10,049
-4% -$1.59M 1.91% 18
2020
Q2 		$37.2M Sell
260,941
-2,605
-1% -$360K 1.8% 19
2020
Q1 		$28.6M Sell
263,546
-3,918
-1% -$565K 1.7% 19
2019
Q4 		$38.9M Buy
267,464
+2,084
+0.8% +$301K 1.91% 19
2019
Q3 		$38.3M Buy
265,380
+1,047
+0.4% +$153K 1.9% 19
2019
Q2 		$39.3M Buy
264,333
+5,015
+2% +$700K 1.97% 19
2019
Q1 		$34.1M Buy
+259,318
New +$31.9M 1.82% 21

Other funds holding LH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fairview Capital Investment Management's LH Position: Q1 2026 in Review

Fairview Capital Investment Management reduced its Labcorp (LH) stake by 0.7% in Q1 2026, selling an estimated $437K and leaving 230,405 shares worth $61.5M. The position accounts for 3.34% of the portfolio, ranked #9.

Fairview Capital Investment Management first reported a position in LH in Q1 2019 and has held it in 29 quarters since. The position peaked at $68.1M in Q4 2021. 1,032 funds tracked by Wall St. Rank hold LH as of Q1 2026.

  • Fairview Capital Investment Management held 230,405 shares of Labcorp worth $61.5M as of Q1 2026.
  • Fairview Capital Investment Management sold 1,615 Labcorp shares in Q1 2026, an estimated $437K.
  • Labcorp made up 3.34% of Fairview Capital Investment Management's portfolio in Q1 2026, its #9 holding.
  • Fairview Capital Investment Management first reported a position in Labcorp in Q1 2019 and has held it in 29 quarters since.
  • Fairview Capital Investment Management's Labcorp position peaked at $68.1M in Q4 2021.
  • 1,032 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.

Based on Fairview Capital Investment Management's 13F filing for Q1 2026, filed 15 May 2026.